Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lenalidomide Following Rituximab and Fludarabine in Untreated Chronic Lymphocytic Leukemia

NCT00860457 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.

NCT NCT00860457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00860457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lenalidomide Following Rituximab and Fludarabine in Untreated Chronic Lymphocytic Leukemia
Lead sponsor
Georgetown University
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2008
Completion date
February 29, 2012
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia